Pulse Biosciences, Inc.
USD28.78
-0.46 (-1.58%)
CEO
Paul Arthur LaViolette
IPO Date
2016-05-18
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Country
US
Open
$29.03
Prev. Close
$29.24
Day Low
$28.50
Day High
$29.03
52W Low
$12.56
52W High
$31.00
Market Cap
$1.99B
Volume
0.01M
| -19.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -95.2% | -71.4% | 0.21 | 6.76 | -13.9 |
| 31 Dec 2022 | FY | -1606.3% | -8357.9% | 2602.5% | -75.1% | -33.79 | 10.39 | -1.6 |
| 31 Dec 2021 | FY | -38.8% | -4489.4% | -178.4% | -117.3% | 0.32 | 4.30 | -6.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -217.2% | -120.4% | 0.50 | 2.95 | -11.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -149.6% | -109.7% | 0.22 | 5.92 | -6.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -56.6% | -53.1% | 0.00 | 19.42 | -5.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -55.6% | -51.3% | 0.00 | 17.39 | -13.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -37.6% | -36.2% | 0.00 | 16.40 | -7.5 |
| -13.3 |
| 30 Sept 2025 | Q3 | -224.4% | -22540.7% | -20.9% | -17.8% | 0.09 | 10.02 | -15.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -18.3% | -15.9% | 0.08 | 12.05 | -13.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -14.2% | -12.6% | 0.07 | 15.58 | -16.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -16.9% | -14.6% | 0.08 | 11.88 | -13.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -16.0% | -13.6% | 0.11 | 11.93 | -21.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -42.2% | -28.2% | 0.32 | 4.57 | -13.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -27.9% | -20.6% | 0.25 | 7.06 | -10.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -26.9% | -20.2% | 0.21 | 6.76 | -14.1 |